Cargando…

Association of anemia and iron parameters with mortality among prevalent peritoneal dialysis patients in Taiwan: the AIM-PD study

In 1996, the National Health Insurance Administration of Taiwan applied a restrictive reimbursement criteria for erythropoiesis-stimulating agents (ESAs) use in patients with chronic kidney disease. The maximal ESAs dosage allowed by insurance is capped at 20,000 U of epoetin per month. Nephrologist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuo, Ko-Lin, Liu, Jia-Sin, Lin, Ming-Huang, Hsu, Chih-Cheng, Tarng, Der-Cherng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786856/ https://www.ncbi.nlm.nih.gov/pubmed/35075212 http://dx.doi.org/10.1038/s41598-022-05200-3

Ejemplares similares

Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM‐HD Study
por: Kuo, Ko‐Lin, et al.
Publicado: (2018)

Risk factors associated with outcomes of peritoneal dialysis in Taiwan: An analysis using a competing risk model
por: Chen, Hsiao-Ling, et al.
Publicado: (2019)

Dipyridamole decreases dialysis risk and improves survival in patients with pre-dialysis advanced chronic kidney disease
por: Kuo, Ko-Lin, et al.
Publicado: (2017)

Baseline Peritoneal Membrane Transport Characteristics Are Associated with Peritonitis Risk in Incident Peritoneal Dialysis Patients
por: Chou, Yi-Hsin, et al.
Publicado: (2022)

Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access
por: Wu, Chih-Cheng, et al.
Publicado: (2017)

Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis
por: Yang, Chih-Yu, et al.
Publicado: (2017)

Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
por: Hirai, Keiji, et al.
Publicado: (2021)

Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study
por: Chen, Yu-Hsin, et al.
Publicado: (2015)

Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients
por: Huang, Jeng-Yi, et al.
Publicado: (2016)

Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study
por: Chang, Yu-Kang, et al.
Publicado: (2015)

Association of iron deficiency anemia with tuberculosis in Taiwan: A nationwide population-based study
por: Chu, Kuo-An, et al.
Publicado: (2019)

Incidence and clinical features of patients with peritoneal dialysis peritonitis complicated by bacteremia
por: Tsai, Chang-Chih, et al.
Publicado: (2018)

Is combined peritoneal dialysis and hemodialysis redundant? A nationwide study from Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2020)

Associations between the Duration of Dialysis, Endotoxemia, Monocyte Chemoattractant Protein-1, and the Effects of a Short-Dwell Exchange in Patients Requiring Continuous Ambulatory Peritoneal Dialysis
por: Wu, Chia-Lin, et al.
Publicado: (2014)

Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis
por: Kuo, Ko-Lin, et al.
Publicado: (2015)

Torus Palatinus in Taiwan Patients Receiving Peritoneal Dialysis and Hemodialysis: A Prospective Observational Study
por: Chang, Pei-Ching, et al.
Publicado: (2020)

Hookworm Anemia in a Peritoneal Dialysis Patient in China
por: Wu, Fuquan, et al.
Publicado: (2016)

Out-of-pocket costs and productivity losses in haemodialysis and peritoneal dialysis from a patient interview survey in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2019)

Association of Fluid Retention With Anemia and Clinical Outcomes Among Patients With Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2015)

Anti-fibrotic effect of decorin in peritoneal dialysis and PD-associated peritonitis
por: Jiang, Na, et al.
Publicado: (2020)

Do Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis Have the Same Clinical Outcomes? A Ten-year Cohort Study in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2016)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Iron Therapy in Chronic Kidney Disease: Days of Future Past
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

A double-blind, randomized, and active-controlled phase III study of Herbiron drink in the treatment of iron-deficiency anemia in premenopausal females in Taiwan
por: Lee, Ching-Tzu, et al.
Publicado: (2016)

Aeromonas sobria peritonitis in a peritoneal dialysis (PD) patient: a case report and review of the literature
por: Song, Panai, et al.
Publicado: (2019)

UMOD Mutations in Chronic Kidney Disease in Taiwan
por: Chen, Huan-Da, et al.
Publicado: (2022)

Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
por: Liao, Chia-Te, et al.
Publicado: (2021)

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis
por: Sarnak, Mark J, et al.
Publicado: (2023)

A Rare Complication of Peritoneal Dialysis (PD) Catheter: Perforation of Sigmoid Colon by Migrating Tip of Peritoneal Dialysis Catheter
por: Afshan, Sabahat, et al.
Publicado: (2020)

Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2017)

Anemia Management in Peritoneal Dialysis: Perspectives From the Asia Pacific Region
por: Li, Philip Kam Tao, et al.
Publicado: (2021)

Serum osteoprotegerin level is positively associated with peripheral artery disease in patients with peritoneal dialysis
por: Lin, Wei-Chen, et al.
Publicado: (2020)

In Peritoneal Dialysis, Is There Sufficient Evidence to Make “PD First” Therapy?
por: Dalal, Pranav, et al.
Publicado: (2011)

Association Between Blood Cadmium Levels and Mortality in Peritoneal Dialysis
por: Lee, Cheng-Chia, et al.
Publicado: (2016)

Peripheral artery disease in peritoneal dialysis and hemodialysis patients: single-center retrospective study in Taiwan
por: Lee, Chun-Chuan, et al.
Publicado: (2012)

Tuberculous peritonitis in patients on peritoneal dialysis: a 35-year experience from a large medical center in Northern Taiwan
por: Yang, Tzu-Yi, et al.
Publicado: (2023)

Hepcidin and iron parameters in children with anemia of chronic disease and iron deficiency anemia
por: Mahajan, Gunjan, et al.
Publicado: (2017)

Author Correction: Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
por: Liao, Chia-Te, et al.
Publicado: (2022)

Oral Tori in Chronic Peritoneal Dialysis Patients
por: Hsu, Chia-Lin, et al.
Publicado: (2016)

Effluent Tenascin-C Levels Reflect Peritoneal Deterioration in Peritoneal Dialysis: MAJOR IN PD Study
por: Hirahara, Ichiro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_820ekt057tlva4dq3sfa8kn5ai